DBVT — DBV Technologies S.A.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1613780 ·
Last close
$16.49
Market Cap
$975.99M
52W High
$23.04
52W Low
$15.04
ADV30
286,725
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -47,900,000 | -47,600,000 | 266,400,000 | 229,200,000 | 58,500,000 |
| Dec 2025 | 0 | — | -45,048,000 | -44,829,000 | 233,718,000 | 194,167,000 | 64,948,000 |
| Sep 2025 | 0 | — | -34,277,000 | -33,164,000 | 110,495,000 | 69,837,000 | 57,641,000 |
| Jun 2025 | 0 | — | -41,110,000 | -41,875,000 | 143,429,000 | 103,207,000 | 57,205,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-150,483,000
Investing CF
$-1,169,000
Financing CF
$365,082,000
CapEx
$-928,000
Dividends Paid
—
Buybacks
$-152,000
EPS Diluted TTM
$-4.60
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-440,700,000
Inventory
—
Receivables
$15,100,000
ST Investments
—
EBIT TTM
$-168,335,000
Pretax Income TTM
$-166,777,000
Interest Exp TTM
—
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,736,000
EBITDA
$-165,162,000
Free Cash Flow
$-87,206,000
Enterprise Value
$728,560,640
Total Cash
$229,200,000
Total Debt
$6,100,000
Shares Out
59,186,686
Trailing EPS
$-4.50
Book Value
$3.52
ROE
-158.9%
ROA
-66.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -147,054,000 | -146,947,000 | 233,718,000 | 64,948,000 | — | -121,181,000 |
| Dec 2024 | 0 | -116,590,000 | -113,918,000 | 65,658,000 | 38,271,000 | — | -104,474,000 |
| Dec 2023 | 0 | -76,433,000 | -72,726,000 | 182,986,000 | 42,799,000 | — | -79,653,000 |
| Dec 2022 | 0 | -96,631,000 | -96,274,000 | 246,518,000 | 52,065,000 | — | -55,666,000 |
TTM Snapshot
Revenues TTM
$3,533,000
NetIncome TTM
$-49,852,000
OpCashFlow TTM
$0
Assets (Latest)
$65,658,000
Forward EPS
$-0.49
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SLDB | Solid Biosciences Inc. | $1.03B | $10.42 | — |
| REPL | Replimune Group, Inc. | $922.56M | $10.99 | — |
| VOR | Vor Biopharma Inc. | $1.04B | $19.14 | — |
| SANA | Sana Biotechnology, Inc. | $1.07B | $3.85 | — |
| ALVO | Alvotech | $1.11B | $3.28 | — |
News headlines (Yahoo Finance, 1h cache)
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
2026-07-07 15:07 · Yahoo
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
2026-07-06 20:30 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading
2026-07-02 15:13 · Yahoo
DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing
2026-06-29 20:00 · Yahoo
European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading
2026-06-29 15:11 · Yahoo
European Equities Traded in US as ADRs Rise in Thursday Trading
2026-06-25 15:06 · Yahoo
DBV Technologies Announces Inclusion in the Euronext Tech Leaders Index
2026-06-23 20:30 · Yahoo
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Tuesday Trading
2026-06-23 15:10 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
2026-06-22 15:06 · Yahoo
DBV Technologies (ENXTPA:DBV) Advances Peanut Patch With New Phase 3 Data And Infant Trial
2026-06-17 20:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.